|To provide additional insights as to the scope of the 4-day intensive, a summary abstract of his second presentation is included below:
Title: Clinical Lifestyle Medicine Strategies for Preventing and Reversing Memory Loss in Alzheimer’s
Evidence-based lifestyle medicine strategies on prevention and reversal of dementia will be presented.
Currently 5.4 million Americans and 30 million world-wide are diagnosed with Alzheimer’s disease (AD).
Of all the various forms of dementia, AD accounts for 80% of the cases.
Of the 318 million people currently living in the United States, 45 million will develop AD.
A woman’s chance of developing AD is now greater than her chance of developing breast cancer.
A recent epidemiological report clarified that AD is now the 3rd leading cause of death in the United States.
In AD treatment, there is not a single drug that gives anything beyond a marginal, unsustained symptomatic effect, with little or no effect on disease progression.
In order to get effective improvements in Alzheimer’s Disease we must address its underlying causes and focus on combination functional and lifestyle medicine strategies that provide comprehensive, programmatic, and network based approaches which are sufficient to achieve epigenetic transformation and neurologic healing through their multiple and necessary synergistic components.
The field of lifestyle medicine is unique in its ability to meet the demands of the above injunction.
Studies published by the UCLA Center for Alzheimer’s Research have documented that up to 88% of MCI and early AD may be reversed within six months after initiating a comprehensive lifestyle medicine focused program.
The six subtypes of AD will be presented and discussed with emphasis on therapeutic implications.
Insulin resistance of the brain will be reviewed as one of the key factors contributing to the pathology of AD along with discussion as to why AD is now referred to as type 3 diabetes and why type 2 diabetes has been referred to as Alzheimer’s of the pancreas.
Case studies will be presented along with evidence-based lifestyle medicine protocols.